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Expression of factor V by resident macrophages
boosts host defense in the peritoneal cavity
Nan Zhang1, Rafael S. Czepielewski1, Nicholas N. Jarjour1, Emma C. Erlich1, Ekaterina Esaulova1, Brian T. Saunders1, Steven P. Grover3,
Audrey C. Cleuren4, George J. Broze2, Brian T. Edelson1, Nigel Mackman3, Bernd H. Zinselmeyer1, and Gwendalyn J. Randolph1
Macrophages resident in different organs express distinct genes, but understanding how this diversity fits into tissue-specific
features is limited. Here, we show that selective expression of coagulation factor V (FV) by resident peritoneal macrophages in
mice promotes bacterial clearance in the peritoneal cavity and serves to facilitate the well-known but poorly understood
“macrophage disappearance reaction.” Intravital imaging revealed that resident macrophages were nonadherent in peritoneal
fluid during homeostasis. Bacterial entry into the peritoneum acutely induced macrophage adherence and associated bacterial
phagocytosis. However, optimal control of bacterial expansion in the peritoneum also required expression of FV by the
macrophages to form local clots that effectively brought macrophages and bacteria in proximity and out of the fluid phase.
Thus, acute cellular adhesion and resident macrophage–induced coagulation operate independently and cooperatively to meet
the challenges of a unique, open tissue environment. These events collectively account for the macrophage disappearance
reaction in the peritoneal cavity.
Introduction
Our understanding of the biology of tissue-residentmacrophages
has evolved greatly in the past decade. Resident macrophages in
most organs arrive during embryogenesis, maintaining them-
selves for long periods via local proliferation (Ginhoux and
Guilliams, 2016). These resident macrophages express special-
ized sets of genes that are distinct between different organs
(Gautier et al., 2012). Even when monocytes are recruited to
these organs during inflammation, the inflammatory macro-
phages they become are reticent to take up the specialized res-
ident phenotype, if they do at all (Gautier et al., 2013; Guilliams
and Scott, 2017; Misharin et al., 2017). It is assumed that spe-
cialized genes expressed by particular resident macrophages
encode products tailored to the specific physiological needs or
constraints of that tissue, but illustration of direct links often
remain unexplored. Transcription factors that regulate special-
ized macrophage gene sets in different organs have, however,
been identified. One such transcription factor is Gata6, which
selectively governs the life cycle of murine resident peritoneal
macrophages, often called large peritoneal macrophages (LPMs;
Gautier et al., 2012, 2014; Okabe and Medzhitov, 2014; Rosas
et al., 2014). In this study, we focused on understanding how
the transcriptional profile of resident peritoneal macrophages
could be linked to the specialized function of these cells.
Results and discussion
A prominent example of tissue-restricted gene expression in
macrophages is the selective detection in LPMs of mRNA for
coagulation factors, including factor V (FV; F5), FVII (F7), and FX
(F10; Fig. 1 A). The latter two factors were also expressed by lung
macrophages, whereas FV was unique to peritoneal macro-
phages. Activated FV is a key cofactor in the common pathway
for activated FX, forming the prothrombinase complex that,
during coagulation, converts prothrombin to thrombin that in
turn converts fibrinogen to fibrin to form clots. Indeed, the co-
agulation pathway was among top pathways selectively en-
riched in LPMs (Gautier et al., 2012). The unique expression of
FV, in particular, among tissue-resident macrophages caused us
to consider the possibility that coagulation may have a key role
in peritoneal macrophage function. The expression of FVII,
important for initiating the extrinsic pathway of coagulation in
complex with tissue factor (TF; F3) that is acutely induced after
tissue damage, led us to consider this pathway of coagulation in
particular.
A classic response to inflammation exhibited by LPMs is
known as the “macrophage disappearance reaction” (MDR), first
described decades ago (Nelson, 1963). In this reaction, LPMs
become irretrievable from lavage just hours after introduction of
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inflammatory stimuli like the bacillus Calmette-Guerin vaccine,
lipopolysaccharide, zymosan, or thioglycollate (Nelson, 1963;
Barth et al., 1995; Davies et al., 2013; Gautier et al., 2013; Meza-
Perez and Randall, 2017). Repopulation of resident macrophages
is slow following the MDR. LPMs are not always restored after
inflammation otherwise appears to have resolved (Gautier et al.,
2013). In the 1960s, Nelson proposed a role for coagulation in the
MDR, because he could fully reverse it by administering hepa-
rin, which can block coagulation or adhesion; MDR was also
reversed to an appreciable but lesser extent by warfarin, which
Figure 1. Coagulation and adhesion additively cooperate to account for the MDR in response to inflammation. (A) Gene array analysis (from ImmGen;
n = 3 separate pools) of classical coagulation factors in major tissue resident macrophages, including those from the spleen, central nervous system (CNS), lung,
and peritoneum. (B) Quantification of LPMs in peritoneal lavage 3 h after zymosan injection i.p. when clotting and/or adhesion was inhibited. (C) Aggregates
retrieved from the peritoneum 5 h after zymosan injection. (D–G) Immunofluorescence staining of the aggregates for fibrin(ogen) and macrophage markers. D
and G are stained frozen sections of the clots; E and F are whole-mount preparations. Scale bars represent 100 µm (D and G), 50 µm (E), and 10 µm (F).
(H) Flow cytometry on peritoneal exudate cells from untreated mice (left), 3 h after zymosan i.p. (middle), and clots 3 h after zymosan i.p. (right). (I)
Quantification of LPMs 3 h after zymosan injection in clots and omenta in WT and Lyz2Cre;Tln1fl/fl mice. One-way ANOVA was used to test statistical signif-
icance. Symbols represent individual mice studied. Error bars represent ± SEM. All experiments were repeated at least two or three times. **, P < 0.01; ***, P <
0.001.
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would more specifically target coagulation (Nelson, 1963). In the
ensuing years, with recognition that fibrin(ogen) participates in
adhesion, the view developed that coagulation factors support
macrophage disappearance by promoting adhesion and migra-
tion (Szaba and Smiley, 2002) to locations like the omentum
during the MDR (Meza-Perez and Randall, 2017). Thus, a clas-
sical role for coagulation in peritoneal host defense was largely
overlooked. Our intravital imaging of the peritoneal cavity
through an intact abdominal wall indicated that a distinct fea-
ture of LPMs, relative to resident macrophages in other organs,
is that they are free floating in peritoneal fluid (Video 1). LPMs
only adhered to the walls of the peritoneal cavity covering vis-
ceral organs after inflammatory stimuli (heat-killed bacteria)
were introduced (Video 1). Cell density in peritoneal fluid was
high, at ∼6.5 × 104/µl (Table 1), ∼20× the concentration of leu-
kocytes in blood (Mouse Phenome Database; The Jackson
Laboratory).
Given this literature and the striking expression of coag-
ulation factors in LPMs, we wondered whether coagulation
might drive important processes in the peritoneum. First, we
confirmed that heparin fully reversed the MDR induced by
1 mg zymosan i.p. (Fig. 1 B). The very selective inhibitor of
thrombin hirudin partially (∼50%) inhibited MDR (Fig. 1 B),
reminiscent of the effect of warfarin relative to heparin
(Nelson, 1963). Heparin has both anticoagulant and anti-
adhesive activity (Woods et al., 1986), and this may explain
why it is more effective at inhibiting MDR compared with
either warfarin or hirudin.
To directly address the role of integrin–mediated adhesion in
MDR, in the same experiments we employed Lyz2Cre;Tln1fl/flmice
(Fig. 1 B) to prevent en bloc activation of integrins through loss
of the integrin activation adaptor talin-1 (Tln1) in lysozyme-
expressing cells (Yago et al., 2015), which includes LPMs and
other myeloid cells like neutrophils (Faust et al., 2000). The
absence of integrin signaling also partially inhibited MDR,
similar to the inhibition achieved with hirudin alone (∼50%).
However, rather than being redundant, the combination of
hirudin and genetic loss of Tln1 had additive effects, such that
when the two interventions were combined, MDR was fully
reversed, mirroring heparin (Fig. 1 B). In addition, because
neutrophil infiltration almost always correlates with MDR after
zymosan injection, we tested the hypothesis that infiltrated
neutrophils cause MDR. Results from depleting neutrophils with
anti-Ly6G mAb (Fig. S1 A) demonstrated the neutrophils were
dispensable as a cause for MDR (Fig. S1 B). Furthermore, neu-
trophil recruitment was unaffected by Tln1 deficiency in this
model (Fig. S1, C and D), which is consistent with previous re-
port (Lim and Su, 2018).We conclude that neutrophil infiltration
does not play a role in MDR in this model. However, integrin–
mediated adhesion is relevant toMDR, but such adhesion cannot
account for a distinct, prominent role of the coagulation cascade
in affecting macrophage removal.
A close physical examination of the peritoneal cavity after
MDR revealed millimeter-sized aggregates within the peritoneal
cavity 3–5 h after i.p. injection of zymosan (Fig. 1 C). These ag-
gregates stained positively for fibrin(ogen) (Fig. 1, D–F), indi-
cating that they were clots, with such staining most easily
appreciated in whole-mount preparations where strands of fi-
brin were observed between clumps of zymosan particles and
cells (Fig. 1, E and F). Clots were also enriched in LPMs identified
by coexpression of Gata6 and ICAM2 (Fig. 1 G), but very few
peritoneal B cells were incorporated into the clots (Fig. S1 E),
despite that peritoneal B cells are almost as abundant as mac-
rophages in the steady state peritoneal fluid. Some macrophages
in clots were loaded with zymosan particles, but other zymosan
particles appeared outside of cells (Fig. 1, E and F), suggesting
that clots were efficient at entrapping debris not yet phagocy-
tized. Clots also incorporated S100A9+ neutrophils, which are
known to be rapidly recruited to the peritoneum after zymosan
is injected i.p. (Fig. 1 D). Flow cytometry confirmed enrichment
of LPMs in the clots, while they were largely absent in the lavage
3 h after i.p. zymosan (Fig. 1 H). Approximately three timesmore
LPMs were recovered in clots compared with the omentum
(Fig. 1 I), indicating that clots are prominent sites for macro-
phage “disappearance” in response to inflammatory triggers.
Consistent with the integrin independence of macrophage in-
clusion in clots, macrophage recovery from clots was unaffected
by Tln1 deficiency (Fig. 1 I), whereas recovery from the omentum
trended downward, consistent with a role for adhesion in re-
taining macrophages in the omentum.
Work beginning in the 1980s revealed that LPMs produce FV
in culture (Osterud et al., 1981), including production of a
functional prothrombinase complex (activated FV/activated FX;
Pejler et al., 2000) long before it was recognized that F5 mRNA
expression was selective to LPMs. Although the liver is a known
source of FV, expression of FV by LPMs led us to hypothesize
these macrophages maintain FV levels in peritoneal fluid in the
steady state. We thus analyzed FV activity in peritoneal fluid
using a one-stage clotting assay. In WT C57BL/6J mice, FV ac-
tivity in peritoneal interstitial fluid was ∼13% of that in plasma
(Fig. 2 A), consistent with the documented poor entry of plasma
proteins as large as FV (a ∼300-kD protein) into interstitial fluid
of molecules (Yang et al., 1998; Michel et al., 2015). Peritoneal
fluid was thus analyzed from F5−/−;AlbF5Tg mice, engineered
such that the liver sustains expression of FV from the albumin
promoter but all other tissues, including LPMs, lack FV (Sun
et al., 2003). These mice displayed a ∼75% reduction in FV ac-
tivity compared with WT peritoneal fluid (Fig. 2 A), raising the
possibility that the major source of FV in the peritoneal fluid was
not the liver.
Table 1. Peritoneal fluid volume, peritoneal cell density, and total cell
and macrophage numbers in 6-wk-old C57BL/6J mice (comparison of
lavage and collection of undiluted fluid)
Volume
(μl ±
SEM)
Cell density
(×104/µl ±
SEM)
Total cells
(×106 ±
SEM)
Gata6+ resident
macrophages
(×106 ± SEM)
Peritoneal
fluid
52.14 ±
4.02 (7)
6.50 ± 0.85 (6) 3.26 ± 0.27 (6) 1.73 ± 0.11 (6)
Lavage N/A N/A 3.20 ± 0.15 (12) 1.81 ± 0 09 (12)
Numbers in parentheses indicate the numbers of mice used. N/A, not
applicable.
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Demonstrating that a major local source of FV was LPMs, FV
activity in peritoneal fluid of the Lyz2Cre;Gata6fl/fl mouse, which
lack most LPMs (Gautier et al., 2014; Okabe and Medzhitov,
2014; Rosas et al., 2014), mirrored the very low level in F5−/−;
AlbF5Tg mice (Fig. 2 A). LPMs are the only immune cell in the
mouse that expresses Gata6 (Gautier et al., 2014). Thus, while
Lyz2Cre is not completely selective to LPMs, Lyz2Cre;Gata6fl/flmice
exhibit a highly selective defect in LPMs (Gautier et al., 2014). As
an additional evaluation, we performed bone marrow trans-
plantation using WT or F5−/−;AlbF5Tg marrow as donors for ir-
radiated WT recipients that would have normal liver FV. With
80–85% reconstitution of resident peritoneal macrophages with
donor marrow (data not shown), mice receiving F5−/−;AlbF5Tg
marrow showed significantly lower FV activity in peritoneal
fluid than mice receiving WT marrow (Fig. 2 A, bars on right).
We then hypothesized that this LPM–derived FV is crucial to
promote early local clotting in the peritoneal fluid. Indeed, the
zymosan-induced MDR in F5−/−;AlbF5Tg mice reduced the MDR
to a similar level as the hirudin-treated group (Fig. 2 B), sug-
gesting that FV from LPMs is critical for the peritoneal clotting
in this model. Thus, we conclude that LPMs produce FV in the
steady state that in turn promotes clotting of local interstitial
fluid during the MDR (Sun et al., 2003).
In the extrinsic coagulation cascade, TF (FIII; F3) initiates
clotting and has in other systems been demonstrated to be
rapidly expressed by macrophages upon activation. We ob-
served rescue of MDR in response to zymosan-injected i.p. in
mice deficient for murine TF that express very low human TF
levels (hF3; ∼1%; mF−/−;LowhF3+/+), in contrast to control mice
with normal TF levels (mF+/+;LowhF3+/+; Fig. 2 C). The 1% of
normal TF levels in the hF3 transgenic mouse can restore via-
bility of the line but has a markedly impaired capacity to initiate
extrinsic coagulation (Parry et al., 1998), while their control
counterparts from a sister line expressing the human transgene
as well as murine F3 exhibited a complete MDR in response to
zymosan (Fig. 2 C). Likewise, the MDR was partially suppressed
in Lyz2Cre;F3fl/flmice (Pawlinski et al., 2010) compared with F3fl/fl
control mice (Fig. 2 C). Even though F3mRNA is not detectable in
resting LPMs (Fig. 1 A), TF can be rapidly (within 1 h) up-
regulated on the LPM surface and is capable of initiating clot-
ting in vitro (data not shown). Thus, it is likely that LPMs
quickly generate enough TF to initiate the extrinsic coagulation
cascade during the MDR.
Finally, we wondered whether clotting of interstitial fluid
had a critical functional role. While clotting of interstitial fluid
would seem irrelevant to hemostasis, we wondered if interstitial
clotting might serve to entrap both free-floating macrophages
and microbes that invade the peritoneum. Indeed, a previous
study revealed that a single dose of heparin or hirudin caused
increased mortality after mice were subjected to cecal-ligation
puncture (Echtenacher et al., 2001), although the role of local
cells and factors remained unclear. To investigate whether LPM-
dependent local peritoneal coagulation controlled peritoneal
infection, we measured the thrombin–antithrombin complex
(TAT), the standard assay to track occurrence of coagulation, in
the peritoneal fluid and plasma over time after i.p. infection
with live E. coli (Fig. 3 A), normalizing the data as a percentage of
maximal TAT in the serum from exogenously clotted plasma.
Both peritoneal and blood TAT were below detection in the
steady state using the assay. However, peritoneal but not blood
TAT complex was detected within 2 h of infection, lasting for at
least 6 h (Fig. 3 A). In tamoxifen-treated Csf1rMeriCreMer;Gata6fl/fl
or Lyz2Cre;Gata6fl/fl mice, which exhibit selectively and greatly
reduced LPMs (Gautier et al., 2014), TAT was an average of 48%
Figure 2. FV and TF from resident peritoneal macrophages are responsible for peritoneal fluid clotting. (A) Quantification of FV activity in plasma or
peritoneal fluid of various genotypes of mice or after bone marrow transplant of indicated donor genotypes into irradiated WT recipients (last bars on the
right). Zym, zymosan. (B) Quantification of LPMs 3 h after zymosan injection. (C) Quantification of LPMs 3 h after zymosan injection. One-way ANOVA was
used to test statistical significance, except for the bone marrow chimera result in B and the hF+/+ groups and F3fl/fl groups in C, which used a two-tailed t test.
Symbols represent individual mice studied. Error bars represent ± SEM. All experiments were repeated at least two or three times. *, P < 0.05; **, P < 0.01; ***,
P < 0.001.
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and 57% lower, respectively, than in control mice upon infection.
Furthermore, F5−/−;AlbF5Tg mice showed comparably reduced
peritoneal TAT after infection (Fig. 3 B). As expected, Tln1 de-
ficiency in macrophages did not affect TAT levels (Fig. 3 B), and
neither did neutrophil depletion (data not shown). These data
indicate that Gata6+ resident macrophages contribute substan-
tially to peritoneal coagulation in an FV-dependent manner
early after infection. Even though it would be anticipated that
the infectious state would increase vascular permeability and
allow for increased influx of plasma–derived proteins, the data
indicate that any role for permeability in bringing in plasma FV
in the few hours after infection is not sufficient to raise TAT to
levels observed in mice that can generate local FV. Nonetheless,
an increase in permeability might account for why TAT levels
are not as low as the basal level of FV observed in resting mice.
We next investigated the functional impact of MDR on local
bacterial clearance during a 4-h period following infection. In-
hibition of both clotting andmacrophage adhesion to collectively
block the MDR dramatically increased CFUs in the peritoneal
fluid compared with untreated mice, clotting-inhibited mice, or
adhesion-blocked mice (Fig. 3 C), strongly suggesting that both
clotting and adhesion are required for optimal bacterial clear-
ance. By examining bacterial numbers that we could retrieve
from the peritoneal cavity 1 min after their installation (Fig. 3 C,
right column) and comparing with all data obtained at 4 h, it was
clear that all CFUs recovered at 4 h were reduced from the
Figure 3. Macrophage adhesion and macrophage-driven clotting cooperatively promote peritoneal bacterial clearance. (A) Quantification of TAT
complex in peritoneal fluid and plasma in the steady state or after E. coli infection. (B)Quantification of TAT complex in peritoneal fluid 4 h after E. coli infection.
Ctrl, control. (C) CFUs per microliter peritoneal fluid from untreated, hirudin-treated WT, Lyz2Cre;Talinfl/fl mice, hirudin-treated Lyz2Cre;Talinfl/fl mice, and
clodronate liposome-treated mice 4 h after E. coli infection. (D) CFUs per microliter peritoneal fluid from Gata6fl/fl and Lyz2Cre;Gata6fl/fl mice 4 h after E. coli
infection. (E) CFUs per microliter peritoneal fluid from C57BL/6J treated with or without hirudin 4 h after E. coli infection. (F) CFUs per microliter peritoneal
fluid from control and F5−/−;AlbF5Tg mice 4 h after E. coli infection. One-way ANOVA was used to test statistical significance, except for C, D, and F and the
F5−/−;AlbF5Tg groups in B, which were examined by a two-tailed t test. Symbols represent individual mice studied. Error bars represent ± SEM. All experiments
were repeated at least two or three times. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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numbers instilled. Thus, CFUs assessed at 4 h served primarily to
assess how efficiently bacteria were cleared rather than to assess
bacterial growth. In the absence of any interference to the MDR,
an average of 98% of bacteria were cleared in 4 h compared
with the number of CFUs retrieved at 1 min. When macrophages
had earlier been depleted from the peritoneal cavity with
clodronate-loaded liposomes without affecting bloodmonocytes,
as per previous protocol (Wang and Kubes, 2016), clearance of
bacteria was much less efficient, at only 49%, indicating the
pivotal role of local macrophages in bacterial removal. With use
of hirudin alone or loss of Tln1 alone, clearance of bacteria av-
eraged 93% and 86%, respectively. Remarkably, when both co-
agulation and adhesion were inhibited, clearance at 4 h
decreased to an average of 64%, approaching the impact that
complete macrophage depletion achieved (Fig. 3 C). Thus, these
data strongly suggest that both coagulation and adhesion opti-
mize bacterial clearance from the peritoneal cavity.
We then wondered if LPMs or LPM-dependent clotting played
a significant role in accounting for the overall role played by
macrophages in bacterial clearance as revealed from the use of the
clodronate-loaded liposomes. Mice genetically lacking the major-
ity of LPMs (Lyz2Cre;Gata6fl/fl) showed CFUs approximately seven
times higher than those of control mice (Fig. 3 D). Deficiency in
hematopoietic FV (F5−/−;AlbF5Tg) also reduced CFU by two- to
threefold (Fig. 3 F), confirming that local FV accounted for the role
of coagulation in local bacterial clearance. Intravital imaging of
clots ex vivo showed Escherichia coli within lysozyme+ cells at the
time of imaging and other motile bacteria not yet engulfed by
phagocytes but nonetheless trapped within the clot (Video 2).
Lastly, we investigated whether the local control of bacteria
by the MDR or clotting had any impact on bacterial dissemina-
tion from the peritoneal cavity to the blood and ultimately the
spleen. Dissemination is a complex evaluation because there can
be roles for leukocytes or coagulation beyond the peritoneum
within the vasculature itself. The most ideal experimental sce-
nario would be one in which the tools applied to the question of
dissemination from the peritoneum would have neutral effects
on CFU in the spleen after E. coli administration in the blood so
that the effects from the peritoneum could be more selectively
evaluated. Thus, we first evaluated whether the tools we used in
the peritoneal cavity that regulate adhesion, including the
Lyz2Cre;Tln1fl/fl mouse strain and heparin, altered CFUs in the
spleen after i.v. delivery, as any effects in this arm of the ex-
periment could confound interpretation of dissemination from
the peritoneum. Indeed, and surprisingly, Lyz2Cre;Tln1fl/fl mice
displayed fewer CFUs in the spleen after E. coli delivery i.v.
(Fig. 4 A). This protective effect of Tln1 deficiency in blood
myeloid cells might be expected to offset our predicted increase
in dissemination of E. coli from the peritoneum. By contrast,
heparin administered i.p. did not show any statistically signifi-
cant effect on CFU in the spleen after i.v. administration of E. coli
(Fig. 4 B). F5−/−;AlbF5Tg mice and hirudin administered i.p. also
had neutral effects on E. coli CFUs in the spleen when E. coliwas
administered i.v. (Fig. 4, B and C). With respect to adhesion,
because Tln1 deficiency was not neutral in the blood–spleen
compartment (Fig. 4 A), we sought to block macrophage adhe-
sion using antibodies rather than Tln1 deficiency. Combined
blockade of β1 and β2 integrins would be expected to interfere
with adhesion of peritoneal macrophages to mesothelial walls
(Bellingan et al., 2002; Cao et al., 2005) and, fortunately, neu-
tralizing mAbs to these molecules had a neutral impact on E. coli
CFUs in the spleen when E. coliwas administered to blood (Fig. 4
B). These data thus indicate that the most optimal tools in hand
to next evaluate the impact of macrophage–mediated coagula-
tion and adhesion on E. coli dissemination from the peritoneum
were F5−/−;AlbF5Tg mice, heparin, or hirudin to block coagula-
tion and combined anti-β1 and -β2 mAbs to block adhesion.
When we next instilled E. coli into the peritoneal cavity to
study its dissemination, mice with a complete loss of MDR
through the use of heparin exhibited markedly elevated CFUs in
the spleen at 16 h after E. coli i.p. instillation (Fig. 4 D). Fur-
thermore, hematopoietic FV-deficient (F5−/−;AlbF5Tg) mice
treated with blocking antibodies against both β1 and β2 integrins
showed significantly increased CFUs in the spleen when E. coli
were administered i.p. (Fig. 4 E). Mice treated with both hirudin
and blocking antibodies against β1 and β2 integrins showed
significantly increased bacterial burden in the spleen at 16 h
after E. coli i.p. instillation compared with those treated with
anti-β1 and β2 mAbs alone (Fig. 4 F), demonstrating that clotting
indeed impacted bacterial dissemination, beyond the impact of
impaired adhesion. Tln1 deficiency in myeloid cells, combined
with hirudin, did not affect dissemination (Fig. 4 G), but this is
likely due to the conflicting roles of Tln1 deficiency in the peri-
toneum (Fig. 1 B) versus the blood (Fig. 4 A). Together, these data
strongly suggest that the two processes that cooperatively and
nonredundantly account for theMDR, coagulation and adhesion,
also cooperatively and nonredundantly function to optimize
bacterial clearance from the peritoneal cavity, which is essential
to contain dissemination.
These studies, in summary, illustrate how specialized gene
expression in a particular macrophage is intimately tied to the
unique characteristics and physiology of the organ. Specifi-
cally, to support high-quality host defense in the capture of
microorganisms that might gain access to the peritoneal
cavity through the digestive tract, resident peritoneal mac-
rophages constitutively produce FV, along with other clotting
factors. This production makes up for the minimal access that
liver–derived FV has to the peritoneum. Expression of FV al-
lows macrophages to generate clots that trap microorganisms
even before they have a chance to be phagocytosed. This form
of host defense is especially relevant in a fast-flowing envi-
ronment of fluid that comprises a challenging space for effi-
cient phagocytosis. While the clots collect microorganisms in
large numbers, additional macrophages adhering within the
omentum and upon visceral organ surfaces undoubtedly
promote capture of organisms that avoided entrapment in
clots. These two mechanisms collectively account for the vast
majority of macrophage disappearance in the context of per-
itoneal inflammation, and our data indicate that both arms of
the MDR, adhesion and coagulation, are required for optimal
host defense. Finally, in many clinical scenarios, therapeutic
agents are used to limit coagulation to minimize its occur-
rence in blood. The present work, however, illustrates that in
the particular tissue microenvironment of the peritoneum,
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resident macrophage–mediated coagulation produces impor-
tant beneficial effects.
Materials and methods
Mice
All C57BL/6J mice were purchased at the age of 8 wk from The
Jackson Laboratory. Lyz2Cre;Tln1fl/fl mice were a kind gift from
Dr. Rodger P. McEver (Oklahoma Medical Research Foundation,
Oklahoma City, OK). Low human TF mice, Lyz2Cre;F3fl/fl mice,
F5−/−;AlbF5Tg mice, Lyz2Cre;Gata6fl/fl mice (now backcrossed to
C57BL/6 background), Lyz2Cre;R26LSL-Tdtomato mice, and Bhlhe40GFP
mice were described previously (Parry et al., 1998; Sun et al.,
2003; Pawlinski et al., 2010; Gautier et al., 2014; Lin et al., 2016;
Wang and Kubes, 2016). Csf1rMeriCreMer;Gata6fl/fl mice (fully
backcrossed to C57BL/6 background) were generated by
crossing Csf1rMeriCreMer mice with Gata6fl/fl mice. Mouse studies
were approved by animal use oversight committees at Wash-
ington University School of Medicine and the University of
North Carolina (studies on TF).
Reagents
Pac Blue anti-CD45 mAb, allophycocyanin anti-ICAM2 mAb,
allophycocyanin/Cy7 anti-CD11b mAb, PE anti-Ly6G mAb,
PerCP/Cy5.5 anti-Ly6C mAb, PE/Cy7 anti-F4/80 mAb, and
anti-ICAM2mAb were all purchased from BioLegend. Anti-S100A9
polyclonal antibody was purchased from R&D Systems
(AF2065-SP). Anti-Gata6 monoclonal antibody was pur-
chased from Cell Signaling Technology (5851). Anti-
fibrin(ogen) polyclonal antibody was purchased from Agilent
Dako (A0080). The Alexa Fluor 594–conjugated heat-killed
bacterial particles were purchased from Thermo Fisher Sci-
entific (E23370). Clodronate-loaded liposome was purchased
from ClodronateLiposomes.org. Recombinant hirudin was
purchased from Aniara Diagnostica (ARE120A). Zymosan was
purchased from Sigma-Aldrich (Z4250). GFP E. coli was pur-
chased from ATCC (ATCC 25922GFP). Human FV–deficient
plasma was purchased from Haematologic Technologies.
Rabbit thromboplastin (44213), Liberase, hyaluronidase,
DNase I, streptokinase, and collagenase D were purchased
from Sigma-Aldrich. Plasminogen was purchased from Lee
Biosolutions.
Flow cytometry
Flow cytometry was performed as described previously (Gautier
et al., 2014). Briefly, peritoneal exudate cells were collected by
flushing the peritoneumwith 6 ml HBSS with 2.5 mMEDTA and
0.2% BSA. Peritoneal clots were collected 3 h after zymosan
injection and digested using a cocktail of 1 mg/ml collagenase D,
50 U/ml streptokinase, 4 U/ml plasminogen, 100 µg/ml Lib-
erase, 100 µg/ml DNase I, and 0.5 mg/ml hyaluronidase in RPMI
with 1% FBS. The digestion was incubated at 37°C for 30min and
Figure 4. MDR restricts bacterial dissemina-
tion out of the peritoneal cavity to the spleen.
(A) CFUs per spleen from Tln1fl/fl mice or Lyz2Cre;
Tln1fl/fl mice at 16 h after i.v. E. coli infection.
(B) CFUs per spleen from mice untreated or
treated with heparin, anti-integrin β1 and
β2 blocking antibodies, or hirudin at 16 h after i.v.
E. coli infection. Differences between groups are
not statistically significant. (C) CFU per spleen
from F5 littermates and F5−/−;AlbF5Tg mice at
16 h after i.v. E. coli infection. Differences are not
statistically significant. Ctrl, control. (D) CFUs
per spleen from untreated and heparin-treated
mice at 16 h after i.p. E. coli infection. (E) CFUs
per spleen from F5 littermates and F5−/−;AlbF5Tg
mice treated with anti-integrin β1 and β2 block-
ing antibodies at 16 h after i.p. E. coli infection.
(F) CFUs per spleen from mice treated with anti-
integrin β1 and β2 blocking antibodies and mice
treated with hirudin and anti-integrin β1 and
β2 blocking antibodies at 16 h after i.p. E. coli
infection. (G) CFUs per spleen from Tln1fl/fl mice
or Lyz2Cre;Tln1fl/fl mice treated with hirudin at
16 h after i.p. E. coli infection. Differences are not
statistically significant. Two-tailed t tests were
used to test statistical significance for A and
C–G. One-way ANOVA was used to test statis-
tical significance for B. Symbols represent indi-
vidual mice studied. Error bars represent ± SEM.
All experiments were repeated at least one to
three times. *, P < 0.05; **, P < 0.01; ***, P <
0.001.
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mixed by pipetting every 5 min. It was then passed through
70-µm cell strainers to collect single-cell suspension for anti-
body staining. All antibodies were incubated with cells on ice
and diluted 1:200. Peritoneal cells and clot digestions were in-
cubated for 30 min with Pac Blue anti-CD45 mAb, allophyco-
cyanin anti-ICAM2 mAb, allophycocyanin/Cy7 anti-CD11b mAb,
PE anti-Ly6G mAb, PerCP/Cy5.5 anti-Ly6C mAb, and PE/Cy7
anti-F4/80mAb and thenwashed, resuspended, and analyzed on
a BD FACSCanto II (BD Biosciences) using FlowJo software.
Peritonitis models
Briefly, 1 mg zymosan or 2 × 107 E. coli ATCC 25922 was injected
i.p. E. coli was washed with sterile PBS before injection. Peri-
toneal exudate cells, peritoneal fluid, blood, or spleens were
collected at different time points after injection. The cell num-
bers were counted using a Nexcelom cell counter.
i.v. E. coli infection model
Briefly, 2 × 108 E. coli ATCC 25922 was injected retro-orbitally.
E. coli was washed with sterile PBS before injection. Spleens
were collected at 16 h after injection. CFUs were counted and
calculated as below.
E. coli burden measurement
E. coli ATCC 25922 was cultured in LB medium with 100 µg/ml
ampicillin overnight. CFUs were calculated based on OD600
and confirmed by plating the serial dilution and culturing
overnight on LB plates with ampicillin. 2 × 107 E. coli was in-
jected i.p., based on this dose as the LD50 from previous
studies (Xiang et al., 2013). 4 h after infection, peritoneal fluid
was collected, diluted accordingly, and cultured overnight on
LB plates with ampicillin to count and calculate CFU on the
next day. Bar graphs were plotted as CFUs per microliter of
peritoneal fluid, which subsequently was used to measure
TAT concentration.
Intravital two-photon microscopy
Bhlhe40GFP mice were anesthetized and placed in a supine
position. The abdominal skin was opened and separated from
the muscle, leaving the peritoneal cavity intact. Some mice
were injected with AF594-conjugated heat-killed E. coli from
the left side of the peritoneal cavity (away from the imaging
region) using a 30G needle while taking images. Images were
collected using a customized Leica SP8 two-photon micro-
scope equipped with a 25×, 0.95 NA water-immersion objec-
tive and a Mai Tai HP DeepSee Laser (Spectra-Physics) tuned
to 900 nm. Fluorescence emission was guided directly to hy-
brid photodetectors. For signal separation, three dichroic
beam splitters (Semrock) were used at 458, 495, and 560 nm
(FF458-Di02, FF495-Di03, and FF560-Di01). Clots from GFP
E. coli–infected mice were immediately placed into an imaging
chamber between 50-µm mesh and a quartz coverslip to keep
it at physiological temperature and was examined for up to
1 h. Most experiments focused on the 30-min time period.
Clots were imaged with 20 to 35 optical sections at 2.5 µm,
each taken at regular time intervals (typically 30 s), in order
to capture cell dynamics within the clot.
FV activity measurement
Whole blood from C57BL/6J mice was drawn from inferior vena
cava with one-tenth volume 3.8% sodium citrate. Plasma was
collected by centrifuging at 2,000 g for 10 min. Peritoneal fluid
was centrifuged at 5,000 g for 10 min, aliquoted, and stored in
a −80°C freezer. FV activity was determined using a one-stage
clotting assay with human FV–deficient plasma, as previously
described, with a Coatron M1 machine. The mouse plasma was
used as standard and set as 100%.
Collection of peritoneal interstitial fluid
Pure peritoneal interstitial fluid was collected as described by
Hartveit and Thunold (1966). Briefly, it was collected by as-
pirating with a 10-µl pipette tip without any anticoagulant,
centrifuged at 2,000 g for 10 min, and stored in a −80°C
freezer.
Bone marrow transplantation
Bone marrow transplantation was performed as described pre-
viously (Zhang et al., 2016). Briefly, bone marrow cells were
isolated from CD45.2 or F5−/−;AlbF5Tg mice. The cells (2 × 106)
were injected i.v. into lethally irradiated 6-8-wk-old CD45.1/
CD45.2 mice (1,100 rad). 6 wk after transplantation, reconsti-
tution was determined by quantitating percentages of CD45.2+
resident peritoneal macrophages with flow cytometry.
TAT ELISA
TAT ELISA-paired antibodies were purchased from Cedarlane
(CL20018K). The ELISA was performed as per the manu-
facturer’s instructions. Mouse plasma was fully clotted by re-
calcification to generate serum that has a maximal amount of
TAT. This serumwas aliquoted and used as the standard. 10 µl of
the peritoneal fluid was diluted 1:10 into the plate. 10 µl of the
serum was diluted 1:10 and set as 100%. Bar graphs were plotted
as the percentages of the serum.
Confocal microscopy
Peritoneal clots were collected 3–5 h after zymosan injection,
fixed in 4% paraformaldehyde overnight at 4°C, transferred into
20% sucrose overnight at 4°C, embedded in Tissue-Tek O.C.T.
Compound (Triangle Biomedical Sciences), and processed into
10-µm sections. After fixation and permeabilization in 4% par-
aformaldehyde for 5 min, cryosections were rinsed with PBS,
incubated in PBS with 3% BSA and 1% Triton at room temper-
ature for 60 min, and then incubated with primary antibodies
(α-ICAM2, α-fibrin(ogen), α-Gata6, and α-S100A9) overnight at
4°C, washed with PBS, and incubated with secondary antibodies
(Cy2, Cy3, and Cy5) at room temperature for 1 h. After washing,
mounting medium was added to the slides. Images were col-
lected using a Leica SP8 confocal microscope. Whole-mount
imaging followed a similar protocol but extended antibody in-
cubations to overnight.
Gene expression analysis
Gene expression analysis in macrophage herein used a previ-
ously described database created by the Immunological Genome
Project (detailed by Gautier et al., 2014).
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Statistics
Statistical analysis was performed using the Student’s t test for
unpaired samples or one-way ANOVA with a post-hoc Tukey’s
multiple comparisons test. Results were considered significant
at P < 0.05. Results display all replicated experiments, and val-
ues are mean ± SEM.
Online supplemental material
Fig. S1 shows coagulation and adhesion additively cooperate to
account for theMDR in response to inflammation. Video 1 shows
intravital imaging of peritoneal macrophages through the intact
abdominal wall. Video 2 shows intravital imaging of a clot after
removal from a mouse 3 h after injection of GFP–E. coli.
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